FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to medicine. What is described is an implanted drug delivery device on the basis of polyurethane for the delivery of biologically active compounds at a constant speed for a long period of time, and a method for preparing it. The device is high biocompatible and bioresistant, and applicable as an implant for patients (human and animals) for the delivery of biologically active compounds to tissues and organs.
EFFECT: implanted device provides the delivery at a constant speed for a long period of time.
26 cl, 5 tbl, 14 dwg, 8 ex
| Title | Year | Author | Number |
|---|---|---|---|
| IMPLANTED OCTREOTIDE DELIVERY DEVICE AND METHOD FOR USING IT | 2009 |
|
RU2549473C2 |
| IMPLANTED RISPERIDONE DELIVERY SYSTEM AND METHODS FOR USING IT | 2009 |
|
RU2510266C2 |
| INTRAVAGINAL DEVICE FOR DRUG DELIVERY | 2012 |
|
RU2607179C2 |
| OCTREOTIDE IMPLANT CONTAINING RELEASING SUBSTANCE | 2009 |
|
RU2521291C2 |
| OCTREOTIDE DELIVERY FROM DRY DOSAGE FORMS | 2009 |
|
RU2518745C2 |
| INTRAVAGINAL DEVICE FOR CONTROLLED DELIVERY OF LUBRICANTS | 2011 |
|
RU2591786C2 |
| DEVICE FOR DRUGS DELIVERY WITH THE DRUG PERMEABLE AND THE DRUGS DELIVERY METHOD | 2014 |
|
RU2666684C2 |
| INTRAOCULAR DRUG DELIVERY SYSTEMS | 2007 |
|
RU2440102C2 |
| METHODS AND COMPOSITIONS CONTAINING CLONIDINE, APPLICABLE FOR TREATING POSTOPERATIVE PAIN | 2009 |
|
RU2510263C2 |
| PREPARATION OF POLYLACTIDE-POLYGLYCOLIDE MICROPARTICLES CHARACTERISED BY SIGMOIDAL RELEASE PROFILE | 2014 |
|
RU2658004C2 |
